Ledger.Open graph →
SEC Form D · filed January 30, 2020

Hoverink Biotechnologies, Inc

Offering
$8.4M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Cyrus Sajna · Los Angeles, CAExec · DirectorDavidra N. Sajna · Los Angeles, CAExec · DirectorSteven Jacolow · Tampa, FLExec · DirectorAEI Net Lease Portfolio XI Depositor, LLC · St. Paul, MNExec · DirectorHans P. Morefield · East Rochester, NYExec · DirectorJohn P. Holton · East Rochester, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗